Cargando…
Action Mechanism Underlying Improvement Effect of Fuzi Lizhong Decoction on Nonalcoholic Fatty Liver Disease: A Study Based on Network Pharmacology and Molecular Docking
OBJECTIVE: This study aimed to decipher the bioactive compounds and potential mechanism of traditional Chinese medicine (TCM) formula Fuzi Lizhong Decoction (FLD) for nonalcoholic fatty liver disease (NAFLD) treatment via an integrative network pharmacology approach. METHODS: The candidate compounds...
Autores principales: | Luo, Zheng, Xia, Lu-Yun, Tang, Yu-Qin, Huang, Lili, Liu, Dan, Huai, Wen-Ying, Zhang, Chun-Jiang, Wang, Yan-Qiu, Xie, Yong-Mei, Yin, Qiao-Zhi, Chen, Yun-Hui, Zhang, Tian-E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794673/ https://www.ncbi.nlm.nih.gov/pubmed/35096103 http://dx.doi.org/10.1155/2022/1670014 |
Ejemplares similares
-
Transcriptomic Analysis of Fuzi Lizhong Decoction for the Treatment of Stomach Ulcers
por: Xin, Yang, et al.
Publicado: (2020) -
Fuzi-Lizhong Decoction Alleviates Nonalcoholic Fatty Liver Disease by Blocking TLR4/MyD88/TRAF6 Signaling
por: Yang, Jiayao, et al.
Publicado: (2022) -
Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway
por: Yang, Jiayao, et al.
Publicado: (2020) -
An Integrated Gut Microbiota and Network Pharmacology Study on Fuzi-Lizhong Pill for Treating Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhen, Zhang, et al.
Publicado: (2021) -
Identification of Active Compounds of Mahuang Fuzi Xixin Decoction and Their Mechanisms of Action by LC-MS/MS and Network Pharmacology
por: Liang, Xiao, et al.
Publicado: (2020)